Cargando…

Poor self-reported adherence to COVID-19-related quarantine/isolation requests, Norway, April to July 2020

To limit SARS-CoV-2 spread, quarantine and isolation are obligatory in several situations in Norway. We found low self-reported adherence to requested measures among 1,704 individuals (42%; 95% confidence interval: 37–48). Adherence was lower in May–June–July (33–38%) compared with April (66%), and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Steens, Anneke, Freiesleben de Blasio, Birgitte, Veneti, Lamprini, Gimma, Amy, Edmunds, W John, Van Zandvoort, Kevin, Jarvis, Christopher I, Forland, Frode, Robberstad, Bjarne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Centre for Disease Prevention and Control (ECDC) 2020
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502884/ https://www.ncbi.nlm.nih.gov/pubmed/32945254 http://dx.doi.org/10.2807/1560-7917.ES.2020.25.37.2001607

Ejemplares similares

Visiting crowded places during the COVID-19 pandemic. A panel study among adult Norwegians
por: Aarø, Leif Edvard, et al.
Publicado: (2022)

Effects of non-compulsory and mandatory COVID-19 interventions on travel distance and time away from home, Norway, 2021
por: Kamineni, Meghana, et al.
Publicado: (2023)

Vaccine effectiveness against infection with the Delta (B.1.617.2) variant, Norway, April to August 2021
por: Seppälä, Elina, et al.
Publicado: (2021)

Re–evaluation of the cost–effectiveness and effects of childhood rotavirus vaccination in Norway
por: Hansen Edwards, Christina, et al.
Publicado: (2017)

Risk conditions in children hospitalized with influenza in Norway, 2017–2019
por: Hauge, Siri Helene, et al.
Publicado: (2020)

Correction to: Risk conditions in children hospitalized with influenza in Norway, 2017–2019
por: Hauge, Siri Helene, et al.
Publicado: (2021)

Effect of Vaccines and Antivirals during the Major 2009 A(H1N1) Pandemic Wave in Norway – And the Influence of Vaccination Timing
por: Freiesleben de Blasio, Birgitte, et al.
Publicado: (2012)

MRSA infections in Norway: A study of the temporal evolution, 2006-2015
por: Di Ruscio, Francesco, et al.
Publicado: (2017)

Compliance with water advisories after water outages in Norway
por: Hyllestad, Susanne, et al.
Publicado: (2019)

The impact of local and national restrictions in response to COVID-19 on social contacts in England: a longitudinal natural experiment
por: Jarvis, Christopher I., et al.
Publicado: (2021)

Etiology of viral respiratory tract infections in hospitalized adults, and evidence of the high frequency of prehospitalization antibiotic treatment in Norway
por: Debes, Sara, et al.
Publicado: (2021)

Estimating Age-Specific Immunity and Force of Infection of Varicella Zoster Virus in Norway Using Mixture Models
por: Del Fava, Emanuele, et al.
Publicado: (2016)

Evaluating costs and health consequences of sick leave strategies against pandemic and seasonal influenza in Norway using a dynamic model
por: Edwards, Christina Hansen, et al.
Publicado: (2019)

Methicillin-Resistant Staphylococcus aureus (MRSA) Is Increasing in Norway: A Time Series Analysis of Reported MRSA and Methicillin-Sensitive S. aureus Cases, 1997–2010
por: Moxnes, John F., et al.
Publicado: (2013)

Analysis of multi-level spatial data reveals strong synchrony in seasonal influenza epidemics across Norway, Sweden, and Denmark
por: Morris, Sinead E., et al.
Publicado: (2018)

Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July–November 2021
por: Starrfelt, Jostein, et al.
Publicado: (2022)

The natural history of varicella zoster virus infection in Norway: Further insights on exogenous boosting and progressive immunity to herpes zoster
por: Marangi, Luigi, et al.
Publicado: (2017)

Trajectories of hospitalisation for patients infected with SARS-CoV-2 variant B.1.1.7 in Norway, December 2020 – April 2021
por: Whittaker, Robert, et al.
Publicado: (2021)

The impact of methicillin-resistant S. aureus on length of stay, readmissions and costs: a register based case-control study of patients hospitalized in Norway
por: Andreassen, A. Elizabeth S., et al.
Publicado: (2017)

Quantifying the impact of physical distance measures on the transmission of COVID-19 in the UK
por: Jarvis, Christopher I., et al.
Publicado: (2020)

Modelling the burden of hepatitis C infection among people who inject drugs in Norway, 1973–2030
por: Meijerink, Hinta, et al.
Publicado: (2017)

Implementation of multiplex PCR diagnostics for gastrointestinal pathogens linked to increase of notified Shiga toxin-producing Escherichia coli cases in Norway, 2007–2017
por: Jenssen, Gaute Reier, et al.
Publicado: (2019)

Clinical Outcome of Viral Respiratory Tract Infections in Hospitalized Adults in Norway: High Degree of Inflammation and Need of Emergency Care for Cases With Respiratory Syncytial Virus
por: Debes, Sara, et al.
Publicado: (2022)

Estimated vaccine effectiveness against SARS-CoV-2 Delta and Omicron infections among health care workers and the general adult population in Norway, August 2021 – January 2022
por: Langlete, Petter, et al.
Publicado: (2023)

Estimating the impact of reopening schools on the reproduction number of SARS-CoV-2 in England, using weekly contact survey data
por: Munday, James D., et al.
Publicado: (2021)

COVID-19 among immigrants in Norway, notified infections, related hospitalizations and associated mortality: A register-based study
por: Indseth, Thor, et al.
Publicado: (2021)

What are the most important infectious diseases among those ≥65 years: a comprehensive analysis on notifiable diseases, Norway, 1993–2011
por: Steens, Anneke, et al.
Publicado: (2014)

Cost-Effectiveness of Mobile Stroke Unit Care in Norway
por: Lund, Ulrikke Højslev, et al.
Publicado: (2022)

Rapid reviews for rapid decision-making during the coronavirus disease (COVID-19) pandemic, Norway, 2020
por: Fretheim, Atle, et al.
Publicado: (2020)

Sudden emergence of a Neisseria gonorrhoeae clade with reduced susceptibility to extended-spectrum cephalosporins, Norway
por: Osnes, Magnus N., et al.
Publicado: (2020)

A compelling demonstration of why traditional statistical regression models cannot be used to identify risk factors from case data on infectious diseases: a simulation study
por: Engebretsen, Solveig, et al.
Publicado: (2022)

Study protocol for a multicenter investigation of reablement in Norway
por: Langland, Eva, et al.
Publicado: (2015)

Emulsion group schedule: April-July, 1961
por: CERN. Geneva. Emulsion Experiments Committee
Publicado: (1961)

Erratum to: Study protocol for a multicenter investigation of reablement in Norway
por: Langeland, Eva, et al.
Publicado: (2015)

Modeling the cost of influenza: the impact of missing costs of unreported complications and sick leave
por: Xue, Yiting, et al.
Publicado: (2010)

Dynamic modelling of costs and health consequences of school closure during an influenza pandemic
por: Xue, Yiting, et al.
Publicado: (2012)

CoMix: comparing mixing patterns in the Belgian population during and after lockdown
por: Coletti, Pietro, et al.
Publicado: (2020)

The Risk of Invasive Pneumococcal Disease Differs between Risk Groups in Norway Following Widespread Use of the 13-Valent Pneumococcal Vaccine in Children
por: Winje, Brita Askeland, et al.
Publicado: (2021)

Burden of medically attended influenza in Norway 2008‐2017
por: Hauge, Siri Helene, et al.
Publicado: (2019)

Memorandum: Request for running time for S91 in m$_{8}$ in June and July
por: CERN. Geneva, et al.
Publicado: (1970)

Cannot write session to /tmp/vufind_sessions/sess_d19gt0bqqatiahumtt92pu0a3v